Tag: mepolizumab
Biologics in Severe Asthma: How Anti-IgE and Anti-IL-5 Therapies Change the Game
Anti-IgE and anti-IL-5 biologics are transforming severe asthma care by targeting specific immune pathways. Learn how omalizumab, mepolizumab, and benralizumab reduce flare-ups, cut steroid use, and restore quality of life for those who don’t respond to standard treatments.
read morerecent posts
Acupuncture for pain is backed by solid science, especially for chronic back pain, osteoarthritis, and headaches. It reduces pain without drugs, has minimal side effects, and works better than placebo in clinical trials. Learn how it works and who benefits most.
Published ON: 10 FebAnti-IgE and anti-IL-5 biologics are transforming severe asthma care by targeting specific immune pathways. Learn how omalizumab, mepolizumab, and benralizumab reduce flare-ups, cut steroid use, and restore quality of life for those who don’t respond to standard treatments.
Published ON: 13 FebDTC prescription drug ads in the U.S. drive higher demand for branded medications, often overshadowing equally effective generics. Research shows ads increase prescriptions but also lead to inappropriate requests and higher costs. Learn how advertising influences patient decisions and healthcare outcomes.
Published ON: 6 FebPatent exclusivity and market exclusivity are two separate legal tools that protect drug prices. Patents cover inventions; FDA exclusivity blocks generics using clinical data-even without a patent. Understanding the difference explains why some drugs stay expensive long after patents expire.
Published ON: 7 FebOsteoporosis weakens bones, increasing fracture risk. Bisphosphonate therapy slows bone loss and reduces fractures. Learn how these treatments work, their benefits, risks, and alternatives for better bone health.
Published ON: 4 Feb